Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL1B | P01584 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19491224 | 0.89 | IL1B (0.36) | IL1BSMN1; SMN2 | |
| SCHEMBL17992234 | 0.81 | CYP4F2 (0.33) | — | |
| SCHEMBL18908833 | 0.81 | IL1B (0.40) | IL1B | |
| SCHEMBL20233496 | 0.81 | IL1B (0.34) | IL1B | |
| SCHEMBL21589881 | 0.81 | IL1B (0.34) | IL1B | |
| SCHEMBL18908823 | 0.78 | IL1B (0.32) | IL1BCNR2 | |
| SCHEMBL24414238 | 0.77 | L3MBTL1 (0.31) | SMN1; SMN2 | |
| SCHEMBL22190267 | 0.74 | SCN9A (0.32) | — | |
| SCHEMBL29427683 | 0.74 | SCN9A (0.32) | — | |
| SCHEMBL24414205 | 0.73 | PTPN11 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3202761-B1 | PYRIDAZINE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2022-03-16 | — | — | EP | disclosed |
| US-9924719-B2 | Pyridazine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-27 | — | — | US | disclosed |
| US-20170295787-A1 | PYRIDAZINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-19 | — | — | US | disclosed |
| EP-3202761-A1 | PYRIDAZINE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2017-08-09 | — | — | EP | disclosed |
| WO-2017090655-A1 | PEST CONTROL COMPOSITION AND USE THEREOF | 住友化学株式会社 | 2017-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170295787-A1 | PYRIDAZINE COMPOUND | C5, C3AR1, H1-3 | IL1B 2176/4885CNR2 70/4885SMN1; SMN2 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.